These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9808415)

  • 41. Detection of anti-pyruvate dehydrogenase complex antibody in primary biliary cirrhosis by an enzyme-linked immunosorbent assay.
    Tsuruya T
    Gastroenterol Jpn; 1990 Aug; 25(4):471-7. PubMed ID: 2210221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies.
    Hazama H; Omagari K; Masuda J; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    J Gastroenterol Hepatol; 2002 Mar; 17(3):316-23. PubMed ID: 11982703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis.
    Briand JP; Andre C; Tuaillon N; Herve L; Neimark J; Muller S
    Hepatology; 1992 Dec; 16(6):1395-403. PubMed ID: 1280244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Primary biliary cirrhosis (PBC)].
    Yanagawa T; Shibata M
    Nihon Rinsho; 2005 May; 63 Suppl 5():490-3. PubMed ID: 15954397
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members.
    Maran R; Dueymes M; Adler Y; Shoenfeld Y; Youinou P
    J Clin Immunol; 1994 Sep; 14(5):323-6. PubMed ID: 7814462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
    Wirth HP; Zala G; Meyenberger C; Ammann R
    Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis.
    Nann D; Berg CP; Preuss BE; Klein R
    BMC Gastroenterol; 2012 Oct; 12():152. PubMed ID: 23095491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver involvement in primary Sjögren's syndrome.
    Skopouli FN; Barbatis C; Moutsopoulos HM
    Br J Rheumatol; 1994 Aug; 33(8):745-8. PubMed ID: 8055202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary biliary cirrhosis--specific anti-mitochondrial antibodies].
    Wenchich L; Krechler T; Horak J; Sedivá A; Bartůnková J; Hansiková H; Martásek P; Zeman J; Svestka T
    Vnitr Lek; 2004 Nov; 50(11):842-5. PubMed ID: 15648964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial.
    Leuschner M; Maier KP; Schlichting J; Strahl S; Herrmann G; Dahm HH; Ackermann H; Happ J; Leuschner U
    Gastroenterology; 1999 Oct; 117(4):918-25. PubMed ID: 10500075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex, the major autoantigen in primary biliary cirrhosis.
    Rowley MJ; McNeilage LJ; Armstrong JM; Mackay IR
    Clin Immunol Immunopathol; 1991 Sep; 60(3):356-70. PubMed ID: 1713816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease.
    Gatselis NK; Zachou K; Norman GL; Gabeta S; Papamichalis P; Koukoulis GK; Dalekos GN
    Autoimmunity; 2013 Nov; 46(7):471-9. PubMed ID: 23777462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis.
    Cha S; Leung PS; Coppel RL; Van de Water J; Ansari AA; Gershwin ME
    Hepatology; 1994 Sep; 20(3):574-83. PubMed ID: 7521314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis.
    Kitami N; Komada T; Ishii H; Shimizu H; Adachi H; Yamaguchi Y; Kitamura T; Oide H; Miyazaki A; Ishikawa M
    Intern Med; 1995 Jun; 34(6):496-501. PubMed ID: 7549131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.